Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BIDIL safely and effectively. See full prescribing information for BIDIL. BIDIL® (isosorbide dinitrate and hydralazine hydrochloride) tablet, for oral use Initial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
BiDil is indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status. There is little experience in patients with NYHA class IV heart failure.
- generic_name
- hydralazine hydrochloride and isosorbide dinitrate
- product_names
- Hydralazine hydrochloride and Isosorbide dinitrate
- ndc
- 24338-010, 24338-010-18, 24338-010-12, 24338-010-09
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en